Invention Grant
![Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase](/docs/US/2020-08-18/US10745420B2/abs.jpg.600x600.jpg)
- Patent Title: Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
-
Application No.: US16539693Application Date: 2019-08-13
-
Publication No.: US10745420B2Publication Date: 2020-08-18
- Inventor: Maria Emilia Di Francesco , Philip Jones , Christopher Lawrence Carroll , Jason Bryant Cross , Michael Garrett Johnson , Sarah Lively
- Applicant: Board of Regents, The University of Texas System , ChemPartner Corporation
- Applicant Address: US TX Austin US CA South San Francisco
- Assignee: Board of Regents, The University of Texas System,ChemPartner Corporation
- Current Assignee: Board of Regents, The University of Texas System,ChemPartner Corporation
- Current Assignee Address: US TX Austin US CA South San Francisco
- Agent Dennis A. Bennett; Cynthia Hathaway; John Desper
- Main IPC: C07D519/00
- IPC: C07D519/00 ; A61P35/00
![Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase](/abs-image/US/2020/08/18/US10745420B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to tetrahydropyrido[4,3-d]pyrimidine based compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.
Public/Granted literature
- US20190367536A1 TETRAHYDROPYRIDO[4,3-d]PYRIMIDINE INHIBITORS OF ATR KINASE Public/Granted day:2019-12-05
Information query
